These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 33489865)

  • 1. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.
    Mu X; Zhao Q; Chen W; Zhao Y; Yan Q; Peng R; Zhu J; Yang C; Lan K; Gu X; Wang Y
    Front Oncol; 2020; 10():526866. PubMed ID: 33489865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of N6-Methyladenosine Modification in Tumors.
    Zhang N; Zuo Y; Peng Y; Zuo L
    J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.
    Gan X; Dai Z; Ge C; Yin H; Wang Y; Tan J; Sun S; Zhou W; Yuan S; Yang F
    Front Oncol; 2022; 12():989353. PubMed ID: 36172147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in
    Li H; Lin J; Cheng S; Chi J; Luo J; Tang Y; Zhao W; Shu Y; Liu X; Xu C
    Front Cell Dev Biol; 2023; 11():1136096. PubMed ID: 37363723
    [No Abstract]   [Full Text] [Related]  

  • 9. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Expression of
    Shi Y; Zheng C; Jin Y; Bao B; Wang D; Hou K; Feng J; Tang S; Qu X; Liu Y; Che X; Teng Y
    Front Oncol; 2020; 10():1126. PubMed ID: 32766145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging-Associated Differences in Epitranscriptomic m6A Regulation in Response to Acute Cardiac Ischemia/Reperfusion Injury in Female Mice.
    Su X; Shen Y; Jin Y; Kim IM; Weintraub NL; Tang Y
    Front Pharmacol; 2021; 12():654316. PubMed ID: 34413770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Transcriptomic Profiling of m6A Modification in Age-Related Hearing Loss.
    Feng M; Zhou X; Hu Y; Zhang J; Yang T; Chen Z; Yuan W
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
    Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
    Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of N6-methyladenosine-related RNA methylation in the mouse hippocampus after acquired hearing loss.
    Zhou X; Jin L; Li Y; Wang Y; Li W; Shen X
    BMC Genomics; 2023 Sep; 24(1):577. PubMed ID: 37759187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.
    Li Y; Ge YZ; Xu L; Xu Z; Dou Q; Jia R
    Front Cell Dev Biol; 2020; 8():579919. PubMed ID: 33015074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.
    Song N; Cui K; Zhang K; Yang J; Liu J; Miao Z; Zhao F; Meng H; Chen L; Chen C; Li Y; Shao M; Zhang J; Wang H
    Front Pharmacol; 2022; 13():933332. PubMed ID: 35784761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.